Bob co-founded HEP in 2006. Prior to co-founding HEP, he was a Managing Member and co-founder of CB Health Ventures (“CBHV”) and its first and second investment funds beginning in 1997. Previous to CBHV, Bob spent three years as the President and COO of Harris & Harris Group, Inc., a publicly traded business development company, and ten years with Credit Suisse First Boston (now Credit Suisse).
Bob is a director of ContinuumRx and AllyAlign Health. He served as a director of Applied Pathways prior to its acquisition by AIM Specialty Health, a division of Anthem, Inc. He also served as a director of SCIO Health Analytics prior to its acquisition by EXLService Holdings, Inc.
Bob received a Bachelor’s and Master’s degree in Chemical Engineering from Massachusetts Institute of Technology and an MBA from Columbia Business School.